Clinical Trial Update: Prostate Cancer Patient Management With 18F-DCFPyL PET/CT [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for prostate cancer exploring 18F-DCFPyL PET/CT imaging across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-DCFPyL PET/CT (18F-DCFPyL)

Snippet

Sponsor: Sir Mortimer B. Davis - Jewish General Hospital | Conditions: Prostate Cancer | Phase 2, Phase 3 | Status: ENROLLING_BY_INVITATION